NCT05804396View on ClinicalTrials.gov

Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 24, 2024

Primary Completion Date

November 24, 2024

Study Completion Date

November 24, 2024

Conditions
Migraine
Interventions
DEVICE

Relivion®

Active stimulation device

Sponsors

Lead Sponsor

Neurolief Ltd.
All Listed Sponsors
lead

Neurolief Ltd.

INDUSTRY

NCT05804396 - Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine | Biotech Hunter | Biotech Hunter